Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma

Malignant melanoma is a highly aggressive skin cancer responsible for 80% of mortality, and the overall median survival in patients with metastatic melanoma is only 6–9 months. Combination treatment through the simultaneous administration of dual drugs in a single nanocarrier has been demonstrated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenyang, Han, Xiuping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Nano Express
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237551/
https://www.ncbi.nlm.nih.gov/pubmed/32430641
http://dx.doi.org/10.1186/s11671-020-3293-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237551/
https://www.ncbi.nlm.nih.gov/pubmed/32430641
http://dx.doi.org/10.1186/s11671-020-3293-3

Ejemplares similares